cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Precigen Inc
8 own
9 watching
Current Price
$1.64
$0.02
(1.23%)
logo-pgen
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
341.37M
52-Week High
52-Week High
2.9
52-Week Low
52-Week Low
1.12
Average Volume
Average Volume
4.32M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization341.37M
icon52-Week High2.9
icon52-Week Low1.12
iconAverage Volume4.32M
iconDividend Yield--
iconP/E Ratio--
What does the Precigen Inc do?
Precigen Inc operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform. It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; biological insect control solutions; technologies for non-browning apple without the use of any flavor-altering chemical or antioxidant additives; commercial aquaculture products; and artwork, children's toys, and novelty goods that are derived from living organisms or enabled by synthetic biology. The company serves health, food, energy, environment, and consumer sectors. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Their name changed to Precigen Inc in 2020 and was founded in 1998 and is based in Germantown, Maryland.
Read More
How much money does Precigen Inc make?
News & Events about Precigen Inc.
PR Newswire
4days ago
Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock PR Newswire GERMANTOWN, Md., Jan. 24, 2023 GERMANTOWN, Md., Jan. 24, 2023 /PRNewswire/ -- Precigen, Inc.(Nasdaq: PGEN) today announced the pricing...
PR Newswire
1month ago
Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T Manufactured Overnight for Next Day Infusion in Relapsed or Refractory Acute Myeloid Leukemia Patients Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T...
Ticker Report
2 months ago
Cantor Fitzgerald started coverage on shares of Precigen (NASDAQ:PGEN Get Rating) in a research note issued to investors on Friday, The Fly reports. The firm issued an overweight rating and a $7.00 price objective on the biotechnology companys stock. A number of other equities ...
PR Newswire
5 months ago
Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics PR Newswire GERMANTOWN, Md., Aug. 22, 2022 Proceeds include $170 million in upfront cash and up to $10 million earn-out over two years GERMANTOWN, Md...
Frequently Asked Questions
Frequently Asked Questions
What is Precigen Inc share price today?
plus_minus_icon
Can Indians buy Precigen Inc shares?
plus_minus_icon
How can I buy Precigen Inc shares from India?
plus_minus_icon
Can Fractional shares of Precigen Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Precigen Inc stocks?
plus_minus_icon
What is today’s traded volume of Precigen Inc?
plus_minus_icon
What is today’s market capitalisation of Precigen Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Precigen Inc?
plus_minus_icon
What percentage is Precigen Inc down from its 52-Week High?
plus_minus_icon
What percentage is Precigen Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.64
$0.02
(1.23%)
logo-pgen
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SI-BONE INC
SI-BONE INC
$17.20
$-0.08 (-0.46 %)
MEIRAGTX HOLDINGS PLC
MEIRAGTX HOLDINGS PLC
$7.95
$0.58 (7.87 %)
IMMATICS NV
IMMATICS NV
$7.92
$0.11 (1.41 %)
AUTOLUS THERAPEUTICS PLC
AUTOLUS THERAPEUTICS PLC
$1.88
$0.02 (1.08 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
SI-BONE INC
SI-BONE INC
$17.20
$-0.08 (-0.46 %)
MEIRAGTX HOLDINGS PLC
MEIRAGTX HOLDINGS PLC
$7.95
$0.58 (7.87 %)
IMMATICS NV
IMMATICS NV
$7.92
$0.11 (1.41 %)
AUTOLUS THERAPEUTICS PLC
AUTOLUS THERAPEUTICS PLC
$1.88
$0.02 (1.08 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00